Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 0.46% | 74.10 | 0.0% | $2395.49m | |
| NVAX | Novavax, Inc. | 1.67% | 170.29 | 99.2% | $1218.87m | |
| SRNE | Sorrento Therapeutics, Inc. | 5.95% | 14.42 | 1.8% | $598.67m | |
| GILD | Gilead Sciences, Inc. | 0.79% | 69.35 | 1.0% | $559.14m | |
| AMGN | Amgen, Inc. | -0.36% | 240.69 | 1.3% | $476.61m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.16% | 620.21 | 2.5% | $429.51m | |
| BNTX | BioNTech SE | -0.10% | 77.00 | 0.0% | $399.56m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.13% | 272.99 | 1.9% | $368.45m | |
| BIIB | Biogen, Inc. | 10.10% | 305.71 | 1.6% | $361.06m | |
| ILMN | Illumina, Inc. | -10.94% | 355.66 | 3.5% | $336.82m | |
| VXRT | Vaxart, Inc. | 1.05% | 9.19 | 0.0% | $280.99m | |
| EBS | Emergent BioSolutions, Inc. | 2.91% | 130.66 | 6.4% | $180.62m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.60% | 103.28 | 2.0% | $166.60m | |
| SGEN | Seattle Genetics, Inc. | -0.83% | 160.45 | 6.0% | $163.01m | |
| IBIO | iBio, Inc. | -6.65% | 3.79 | 0.2% | $158.51m |
Company Profile
BioCardia, Inc. operates as a clinical-stage regenerative medicine company. It develops novel therapeutics for cardiovascular diseases. The firm offers proprietary comprehensive biotherapeutic solutions for cardiovascular disease under the CardiAMP and CardiALLO brand. It operates in only one business segment, which is a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. The company was founded on January 12, 1994 and is headquartered in San Carlos, CA.